The latest closing stock price for Bone Biologics as of June 27, 2025 is 4.58.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -68.44% compound annual growth rate over 9 years.
The all-time high Bone Biologics stock closing price was 212400.00 on August 10, 2017.
The Bone Biologics 52-week high stock price is 25.49, which is 456.6% above the current share price.
The Bone Biologics 52-week low stock price is 3.42, which is 25.3% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 7.08.
An investor who bought $1,000 worth of Bone Biologics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -68.44% compound annual growth rate over 9 years.
The all-time high Bone Biologics stock closing price was 212400.00 on August 10, 2017.
The Bone Biologics 52-week high stock price is 25.49, which is 456.6% above the current share price.
The Bone Biologics 52-week low stock price is 3.42, which is 25.3% below the current share price.
The average Bone Biologics stock price for the last 52 weeks is 7.08.